Cedars-Sinai Medical Center in Los Angeles is the focus of a U.S. Food and Drug Administration investigation into more than 200 cases of overexposure to radiation during CT brain perfusion studies.
FDA CT overdose probe focuses on Cedars-Sinai
Oct 12, 2009
Latest in CT
Thirona receives FDA clearance for LungQ 4 software
October 16, 2025
PET/CT reveals ‘chemo brain’ regions in leukemia patients
October 16, 2025
Nurea gets U.S. FDA nod for CT software
October 15, 2025